Fractyl Health (GUTS) Total Liabilities (2023 - 2026)
Fractyl Health's (GUTS) quarterly Total Liabilities came in at $78.0 million in Q1 2026, up 1.75% YoY from $76.7 million in Q1 2025, and down 30.32% on a QoQ basis from $111.9 million in Q4 2025.
Fractyl Health (GUTS) Total Liabilities (2023 - 2026) Analysis & Trends
Fractyl Health (GUTS) has 4 years of Total Liabilities data on file, last reported at $78.0 million in Q1 2026.
- Quarterly Total Liabilities rose 1.75% year-over-year to $78.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $78.0 million (up 1.75% YoY) and the FY2025 annual result came in at $111.9 million, up 40.54% from the prior year.
- Total Liabilities declined to $78.0 million in Q1 2026, from $111.9 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $117.4 million in Q3 2025 to a low of $75.7 million in Q2 2024.
- A 4-year average of $89.0 million and a median of $79.5 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2024 — Total Liabilities tumbled 30.09% — and 2025, when it soared 53.32%.
- Tracing GUTS's Total Liabilities over 4 years: stood at $113.9 million in 2023, then slumped by 30.09% to $79.7 million in 2024, then soared by 40.54% to $111.9 million in 2025, then slumped by 30.32% to $78.0 million in 2026.
- The last three Total Liabilities figures came in at $78.0 million (Q1 2026), $111.9 million (Q4 2025), and $117.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.20 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.35 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 10.03 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 3.22 Bn |
| 10 | Fractyl Health | 109.12 Mn | 109.12 Mn | - | 83.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 83.64 Mn |
| Mar 31, 2026 | 78.01 Mn |
| Dec 31, 2025 | 111.94 Mn |
| Sep 30, 2025 | 117.45 Mn |
| Jun 30, 2025 | 80.22 Mn |
| Mar 31, 2025 | 76.67 Mn |
| Dec 31, 2024 | 79.65 Mn |
| Sep 30, 2024 | 76.60 Mn |
| Jun 30, 2024 | 75.68 Mn |
| Mar 31, 2024 | 79.34 Mn |
| Dec 31, 2023 | 113.94 Mn |